The use of hormonal contraception appears to be appropriate in many women with lupus, according to research published in the August issue of Obstetrics & Gynecology.
The use of hormonal contraception appears to be appropriate in many women with lupus, according to research published in the August issue of Obstetrics & Gynecology.
Kelly R. Culwell, MD, of the World Health Organization in Geneva, and colleagues analyzed data from 13 studies involving women using contraception after being diagnosed with systemic lupus erythematosus (SLE).
Two randomized controlled trials offered good evidence that women with inactive or stable active lupus didn’t have increased flares or worsening disease activity from using combined oral contraceptives, and no increase in disease activity was seen with progestogen-only contraceptives across four studies. However, the authors note, thrombosis may be a concern with oral contraceptive use in women with positive antiphospholipid antibodies. Copper intrauterine devices don’t appear to be linked to worsening disease activity or infection.
“Available evidence indicates that many women with SLE can be considered good candidates for most contraceptive methods, including hormonal contraceptives. Women with positive antiphospholipid antibodies are at significantly increased risk of arterial and venous thrombosis and therefore the use of combined hormonal methods should be avoided in these women," the authors conclude. “Overall, the benefits of contraception for many women with SLE likely outweigh the risks of unintended pregnancy.”
Culwell KR, Curtis KM, Del Carmen Cravioto M. Safety of contraceptive method use among women with systemic lupus erythematosus: a systematic review.
Obstet Gynecol.
2009;114:341-353.
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More